Ulipristal
| Title | Journal |
|---|---|
| Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review. | Frontiers in pharmacology 20150101 |
| Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day. | Journal of clinical pharmacy and therapeutics 20130801 |
| Emergency contraception. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20130301 |
| Ulipristal acetate as an emergency contraceptive agent. | Expert opinion on pharmacotherapy 20120901 |
| Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment. | Expert opinion on drug metabolism & toxicology 20120701 |
| Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2. | Investigational new drugs 20120601 |
| Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells. | American journal of reproductive immunology (New York, N.Y. : 1989) 20120601 |
| Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. | Breast cancer research and treatment 20120101 |
| Updates in hormonal emergency contraception. | Pharmacotherapy 20110901 |
| Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. | Fertility and sterility 20110201 |
| Update on emergency contraception. | Advances in therapy 20110201 |
| Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health. | The Annals of pharmacotherapy 20110101 |
| [Update on current care guidelines: emergency contraception]. | Duodecim; laaketieteellinen aikakauskirja 20110101 |
| Indian Hedgehog and its targets in human endometrium: menstrual cycle expression and response to CDB-2914. | The Journal of clinical endocrinology and metabolism 20101201 |
| Ulisprisal acetate: a novel molecule and 5-day emergency contraceptive. | Obstetrics and gynecology 20101201 |
| Is it worth paying more for emergency hormonal contraception? The cost-effectiveness of ulipristal acetate versus levonorgestrel 1.5 mg. | The journal of family planning and reproductive health care 20101001 |
| Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. | Human reproduction (Oxford, England) 20100901 |
| Ulipristal acetate for emergency contraception. | Drugs of today (Barcelona, Spain : 1998) 20100901 |
| Ulipristal - a new emergency contraceptive pill. | Drug and therapeutics bulletin 20100801 |
| Progesterone receptor modulators. | The journal of family planning and reproductive health care 20100701 |
| Ulipristal acetate for emergency contraception? | Lancet (London, England) 20100508 |
| Ulipristal acetate for emergency contraception? | Lancet (London, England) 20100508 |
| Translational research in women's health: from bedside to bench and from bench to bedside. | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20100501 |
| Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. | Seminars in reproductive medicine 20100501 |
| Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. | Fertility and sterility 20100401 |
| Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques. | Contraception 20100401 |
| LNG may still be the best oral EC option. | The journal of family planning and reproductive health care 20100401 |
| Ulipristal. Postcoital contraception: no better than levonorgestrel. | Prescrire international 20100401 |
| Emergency contraception: update and review. | Seminars in reproductive medicine 20100301 |
| Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. | Lancet (London, England) 20100213 |
| Towards more effective emergency contraception? | Lancet (London, England) 20100213 |
| Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. | Human reproduction (Oxford, England) 20100201 |
| Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. | Obstetrics and gynecology 20100201 |
| The need to take a 'new look' at emergency contraception. | The journal of family planning and reproductive health care 20100101 |
| Clinical utility of progesterone receptor modulators and their effect on the endometrium. | Current opinion in obstetrics & gynecology 20090801 |
| Persistence of an intact endometrial matrix and vessels structure in women exposed to VA-2914, a selective progesterone receptor modulator. | The Journal of clinical endocrinology and metabolism 20081101 |
| CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. | Obstetrics and gynecology 20080501 |
| Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. | Molecular human reproduction 20080301 |
| The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner. | International journal of cancer 20080101 |
| Action of progesterone receptor modulators on uterine leiomyomas. | Clinical and experimental obstetrics & gynecology 20080101 |
| Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids. | Current opinion in investigational drugs (London, England : 2000) 20071001 |
| Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. | The Journal of clinical endocrinology and metabolism 20070901 |
| Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas. | Contraception 20070601 |
| Progesterone and progesterone receptor modulator in uterine leiomyoma growth. | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070401 |
| A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. | Molecular endocrinology (Baltimore, Md.) 20061101 |
| Emergency contraception: politics and science move forward. | Obstetrics and gynecology 20061101 |
| Progesterone receptor modulator for emergency contraception: a randomized controlled trial. | Obstetrics and gynecology 20061101 |
| Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. | Human reproduction (Oxford, England) 20060901 |
| Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. | Gynecologic and obstetric investigation 20060101 |
| Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. | The Journal of clinical endocrinology and metabolism 20050201 |
| Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. | Human reproduction update 20050101 |
| In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone. | The Journal of steroid biochemistry and molecular biology 20040301 |
| Pharmacologic properties of CDB(VA)-2914. | Steroids 20031101 |
| Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. | Steroids 20031101 |
| Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women. | Human reproduction (Oxford, England) 20030901 |
| CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. | Molecular and cellular endocrinology 20020225 |